Research into the potential role of Natural Killer (NK) cells in treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS), and multiple sclerosis is gaining momentum. These cells, integral to the innate immune system, are known for their ability to identify and eliminate infected or abnormal cells, and their involvement in inflammatory responses. Although the clinical evidence supporting NK cell therapy for these conditions is still in its infancy, scientists are delving deeper into how immune activity, particularly involving NK cells, could influence neurodegenerative processes.
In a Phase I clinical study published in 2025, researchers explored the safety of administering expanded NK cells to Alzheimer’s patients. The study included 11 participants, with 10 completing the assessment, who received autologous, non-genetically modified expanded NK cell infusions every three weeks. While the primary focus was on safety, researchers also monitored changes in cognitive functions and cerebrospinal fluid biomarkers linked to neuroinflammation and neurodegeneration, such as pTau181 and GFAP. The study reported no adverse effects directly linked to the NK cell product and noted preliminary changes in some cognitive and biomarker measures. However, the small scale of this study highlights the need for larger, more comprehensive trials to understand the potential clinical benefits of NK cell therapy in Alzheimer’s treatment.
In Parkinson’s disease research, preclinical studies have sparked interest in the role of NK cells. A 2020 study published in the Proceedings of the National Academy of Sciences revealed that NK cells could interact with and break down alpha-synuclein aggregates in laboratory and animal models. The absence of NK cells in a mouse model led to increased alpha-synuclein pathology and neuroinflammation, suggesting these cells might help regulate immune activity associated with Parkinson’s. Nonetheless, the evidence remains largely preclinical, with no definitive proof that NK cell administration could be an effective treatment for Parkinson’s in humans.
The complexity of NK cells’ roles in neurological disorders is becoming increasingly apparent. Different NK cell populations exhibit diverse functions, and their effects may vary depending on the disease type, stage, and tissue environment. Consequently, simply increasing NK cell numbers may not yield beneficial outcomes. Researchers are investigating the specific NK cell populations, activation states, doses, and treatment schedules that might prove useful. Critical questions about the cells’ ability to affect the central nervous system, their longevity, the patients who might benefit, and the potential for altering long-term disease progression remain unanswered.
While NK cells are recognized as active participants in immune surveillance and regulation, their therapeutic potential in neurodegenerative diseases is not yet established. Current research highlights their interaction with neuroinflammation and abnormal protein aggregates, particularly alpha-synuclein. However, NK cell therapy remains an investigational area of cellular medicine, requiring further clinical studies to determine its efficacy and long-term safety. Those considering cellular therapies should consult with healthcare professionals to understand the scientific evidence, safety information, and regulatory status. This article is intended for educational purposes and should not be considered medical advice.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.